1. Home
  2. Diagnosis of MDS
  3. What is involved in screening for MDS?

Expert Video - What is involved in screening for MDS?

MDS experts, Dr Alan List and Dr David Sallman, discuss that there is currently no standardized screening test for myelodysplastic syndromes (MDS). Patients who have persistent low blood counts (cytopenias) might be referred to a hematologist to test for MDS. Patients who are at risk should be followed closely for any unusual changes or progression.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.

Please rate this content:
Animation - Diagnosis of MDS
Animation - Diagnosis of MDS
Slide Show - Diagnosis of MDS
Slide Show - Diagnosis of MDS
Expert Videos
How is MDS diagnosed?
1. How is MDS diagnosed?
What is involved in screening for MDS?
2. What is involved in screening for MDS?
What is genetic testing for MDS?
3. What is genetic testing for MDS?
What are the clinical features and symptoms of MDS?
4. What are the clinical features and symptoms of MDS?
What are the overlap syndromes that have features of MDS?
5. What are the overlap syndromes that have features of MDS?
What is the prognostic classification of MDS?
6. What is the prognostic classification of MDS?
Patient Videos
George's story: How was your MDS diagnosed?
7. George's story: How was your MDS diagnosed?

Other Modules:

Understanding Myelodysplastic Syndromes

Understanding Myelodysplastic Syndromes

Understanding MDS-related Anemia

Understanding MDS-related Anemia

Understanding Erythropoiesis

Understanding Erythropoiesis

Diagnosis of MDS

Diagnosis of MDS

Understanding Genetic Mutations in MDS

Understanding Genetic Mutations in MDS

Management and Treatment of MDS

Management and Treatment of MDS

Managing and Treating MDS-related Anemia

Managing and Treating MDS-related Anemia

Mutation-Driven Therapy in MDS

Mutation-Driven Therapy in MDS

Blood and Marrow Transplantation in MDS

Blood and Marrow Transplantation in MDS

 

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.